Literature DB >> 15589853

Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.

Anna Pia Ferraretti1, Luca Gianaroli, Maria C Magli, Arianna D'angelo, Valeria Farfalli, Nadia Montanaro.   

Abstract

OBJECTIVE: To investigate the role of exogenous LH in controlled ovarian hyperstimulation for assisted reproductive technologies.
DESIGN: Prospective randomized study.
SETTING: SISMER fertility unit. PATIENT(S): Women showing a hyporesponsiveness to FSH under GnRH agonist down-regulation were randomized into three groups: group A (n = 54) received an increased dosage of FSH; group B (n = 54) was administered recombinant LH in addition to the increased dose of FSH; group C (n = 22) was given additional FSH and LH using hMG as a combined drug. Fifty-four age-matched women with no need to increase the FSH dose were included as a control group (D). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Implantation and live birth rate per started cycles. RESULT(S): In group B, the pregnancy and implantation rates were statistically higher when compared with groups A and C and did not differ from the control group for normal response. The live birth rate was similar in groups B and D but was half as high in groups A and C. CONCLUSION(S): Hyporesponsiveness to FSH could be related to iatrogenic LH deficiency that, in turn, could affect oocyte competence. Addition of a small amount of recombinant LH is able to rescue oocyte competence to produce viable embryos.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589853     DOI: 10.1016/j.fertnstert.2004.06.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  38 in total

1.  Lutropin alfa: a viewpoint by Giuseppe De Placido, Roberto Clarizia and Carlo Alviggi.

Authors:  Giuseppe De Placido; Roberto Clarizia; Carlo Alviggi
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.

Authors:  Kyono Koichi; Nakajo Yukiko; Kumagai Shima; Sasaki Sachiko
Journal:  J Assist Reprod Genet       Date:  2006-06-20       Impact factor: 3.412

3.  Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF.

Authors:  Jessica B Spencer; Aimee S Browne; Susannah D Copland; Donna R Session
Journal:  Reprod Biol Endocrinol       Date:  2010-03-23       Impact factor: 5.211

4.  Predicting aneuploidy in human oocytes: key factors which affect the meiotic process.

Authors:  L Gianaroli; M C Magli; G Cavallini; A Crippa; A Capoti; S Resta; F Robles; A P Ferraretti
Journal:  Hum Reprod       Date:  2010-07-08       Impact factor: 6.918

Review 5.  Lutropin alfa.

Authors:  Sohita Dhillon; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Shabnam Khodabakhshi; Mohammad Reza Akhoond; Fatemeh Hasani
Journal:  J Assist Reprod Genet       Date:  2012-09-07       Impact factor: 3.412

7.  Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.

Authors:  Marzia Barberi; Beatrice Ermini; Maria Beatrice Morelli; Michele Ermini; Sandra Cecconi; Rita Canipari
Journal:  J Assist Reprod Genet       Date:  2012-11-28       Impact factor: 3.412

Review 8.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

9.  "hCG priming" effect in controlled ovarian stimulation through a long protocol.

Authors:  Panagiotis Beretsos; George A Partsinevelos; Eleni Arabatzi; Peter Drakakis; Depy Mavrogianni; Elli Anagnostou; Kostas Stefanidis; Aris Antsaklis; Dimitris Loutradis
Journal:  Reprod Biol Endocrinol       Date:  2009-08-31       Impact factor: 5.211

10.  Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: a retrospective study.

Authors:  Gottumukkala Achyuta Rama Raju; S C Teng; Prathigudupu Kavitha; Balabomma Kavitha Lakshmi; Cheemakurthi Ravikrishna
Journal:  Reprod Med Biol       Date:  2012-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.